Transcription of Screening for Hepatitis B Virus (HBV) Infection (NCD 210.6 ...
{{id}} {{{paragraph}}}
Example: biology
Screening for Hepatitis B Virus (HBV) Infection (NCD 210.6 ...
Screening for Hepatitis B Virus (HBV) Infection (NCD ) Page 1 of 5 UnitedHealthcare Medicare Advantage Policy Guideline Approved 06/09/2021 Proprietary Information of UnitedHealthcare. Copyright 2021 United HealthCare Services, Inc. UnitedHealthcare Medicare Advantage Policy Guideline Screening for Hepatitis B Virus (HBV) Infection (NCD ) Guideline Number: Approval Date: June 9, 2021 Terms and Conditions Table of Contents Page Policy Summary .. 1 Applicable Codes .. 2 Questions and Answers .. 3 References .. 3 Guideline History/Revision Information .. 4 Purpose .. 4 Terms and Conditions .. 4 Policy Summary See Purpose Overview Hepatitis B Virus (HBV) is transmitted by exposure to blood or blood-containing body fluids such as serum, semen or saliva. HBV Infection attacks the liver and leads to inflammation. An infected person may initially develop symptoms such as nausea, anorexia, fatigue, fever and abdominal pain, or may be asymptomatic.
Hepatitis B screening in non-pregnant, high risk individual includes hepatitis B surface antigen (HBSAG) followed by a neutralizing confirmatory test for initially reactive results, and antibodies to HBSAG (anti-HBS) and hepatitis B core antigen (anti-HBC) Place of …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: